Xu L - Search Results

1

Intratumoral microbial heterogeneity affected tumor immune microenvironment and determined clinical outcome of HBV-related HCC.

Li S, Xia H, Wang Z, Zhang X, Song T, Li J, Xu L, Zhang N, Fan S, Li Q, Zhang Q, Ye Y, Lv J, Yue X, Lv H, Yu J, Lu W. Li S, et al. Among authors: xu l. Hepatology. 2023 Oct 1;78(4):1079-1091. doi: 10.1097/HEP.0000000000000427. Epub 2023 May 1. Hepatology. 2023. PMID: 37114494 Free PMC article.

2

Association of HBV serological markers with host antiviral immune response relevant hepatic inflammatory damage in chronic HBV infection.

Jiang B, Wang L, Liu H, Wang L, Su R, Xu L, Wei G, Li J, Lu F, Chen X. Jiang B, et al. Among authors: xu l. J Med Virol. 2024 Apr;96(4):e29569. doi: 10.1002/jmv.29569. J Med Virol. 2024. PMID: 38549467

3

A novel model based on serum N-glycan markers for evaluating stage of liver necroinflammation in treatment-naïve chronic hepatitis B patients.

Su R, Yan L, Jiang B, Li J, Li P, Liu Y, Miao J, Chen C, Xu L, Ren L, Mi Y. Su R, et al. Among authors: xu l. J Med Virol. 2024 Aug;96(8):e29863. doi: 10.1002/jmv.29863. J Med Virol. 2024. PMID: 39164985

4

Clinical and histological features under different nomenclatures of fatty liver disease: NAFLD, MAFLD, MASLD and MetALD.

Chen L, Tao X, Zeng M, Mi Y, Xu L. Chen L, et al. Among authors: xu l. J Hepatol. 2024 Feb;80(2):e64-e66. doi: 10.1016/j.jhep.2023.08.021. Epub 2023 Sep 14. J Hepatol. 2024. PMID: 37714381 No abstract available.

5

Direct-acting antivirals failed to reduce the incidence of hepatocellular carcinoma occurrence in hepatitis C virus associated cirrhosis: A real-world study.

Tao XM, Zeng MH, Zhao YF, Han JX, Mi YQ, Xu L. Tao XM, et al. Among authors: xu l. World J Hepatol. 2024 Jan 27;16(1):41-53. doi: 10.4254/wjh.v16.i1.41. World J Hepatol. 2024. PMID: 38313240 Free PMC article.

6

Noninvasive tests maintain high accuracy for advanced fibrosis in chronic hepatitis B patients with different nomenclatures of steatotic liver disease.

Chen L, Tao X, Zeng M, Li Y, Han J, Wang Y, Liu Y, Shi R, Su R, Xu L, Mi Y. Chen L, et al. Among authors: xu l. J Med Virol. 2024 Apr;96(4):e29613. doi: 10.1002/jmv.29613. J Med Virol. 2024. PMID: 38634477

7

Disseminated Talaromyces marneffei infection after renal transplantation: A case report and literature review.

Xu L, Chen X, Yang X, Jiang H, Wang J, Chen S, Xu J. Xu L, et al. Among authors: xu j. Front Cell Infect Microbiol. 2023 Feb 2;13:1115268. doi: 10.3389/fcimb.2023.1115268. eCollection 2023. Front Cell Infect Microbiol. 2023. PMID: 36816584 Free PMC article. Review.

8

Development and validation of a nomogram for assessing hepatocellular carcinoma risk after SVR in hepatitis C patients with advanced fibrosis and cirrhosis.

Xu S, Qiu L, Xu L, Liu Y, Zhang J. Xu S, et al. Among authors: xu l. Infect Agent Cancer. 2024 Apr 25;19(1):17. doi: 10.1186/s13027-024-00578-3. Infect Agent Cancer. 2024. PMID: 38664813 Free PMC article.

9

Establishment and validation of an adherence prediction system for lifestyle interventions in non-alcoholic fatty liver disease.

Zeng MH, Shi QY, Xu L, Mi YQ. Zeng MH, et al. Among authors: xu l. World J Gastroenterol. 2024 Mar 14;30(10):1393-1404. doi: 10.3748/wjg.v30.i10.1393. World J Gastroenterol. 2024. PMID: 38596499 Free PMC article.

10

Association of intrinsic capacity with incident type 2 diabetes mellitus in older Chinese: Guangzhou Biobank Cohort Study.

Gao WX, Liu J, Wang J, Jin YL, Yeung SLA, Lam TH, Zhang WS, Xu L. Gao WX, et al. Among authors: xu l. Arch Gerontol Geriatr. 2024 Nov 9;129:105687. doi: 10.1016/j.archger.2024.105687. Online ahead of print. Arch Gerontol Geriatr. 2024. PMID: 39581158

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

41,326 results

Search Page

Filters